- Home
- LNTH vs LOPE Comparison
LNTH vs LOPE Comparison
Compare LNTH & LOPE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LNTH | LOPE |
|---|---|---|
| Founded | 1956 | 1949 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Other Consumer Services |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.9B | 4.6B |
| IPO Year | 2014 | 2008 |
Fundamental Metrics
Financial Performance| Metric | LNTH | LOPE |
|---|---|---|
| Price | $79.57 | $163.51 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 2 |
| Target Price | $83.20 | ★ $220.00 |
| AVG Volume (30 Days) | ★ 1.0M | 298.7K |
| Earning Date | 05-25-2026 | 05-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | 3.41 | ★ 7.71 |
| Revenue | $343,374,000.00 | ★ $511,257,000.00 |
| Revenue This Year | N/A | $8.76 |
| Revenue Next Year | $13.47 | $5.99 |
| P/E Ratio | $23.56 | ★ $21.28 |
| Revenue Growth | ★ 3.62 | N/A |
| 52 Week Low | $47.27 | $149.37 |
| 52 Week High | $108.86 | $223.04 |
Technical Indicators
Market Signals| Indicator | LNTH | LOPE |
|---|---|---|
| Relative Strength Index (RSI) | 60.94 | 49.75 |
| Support Level | $77.38 | $151.84 |
| Resistance Level | $83.53 | $169.95 |
| Average True Range (ATR) | 3.71 | 4.74 |
| MACD | 0.28 | 0.68 |
| Stochastic Oscillator | 60.42 | 69.00 |
Price Performance
Historical ComparisonAbout LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About LOPE Grand Canyon Education Inc.
Grand Canyon Education Inc is a publicly traded education services company dedicated to serving colleges and universities. GCE's university partner is Grand Canyon University, an Arizona non-profit corporation that operates a comprehensive regionally accredited university that offers graduate and undergraduate degree programs, emphases, and certificates across nine colleges both online, on the ground at its campus in Phoenix, Arizona and at four off-site classroom and laboratory sites. The Company generates all of its revenue through services agreements with its university partners.